Helicobacter pylori infection medical therapy

Helicobacter pylori infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Gastritis Peptic ulcer disease Gastric adenocarcinoma MALT lymphoma
Causes
Differentiating Helicobacter pylori infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Guideline Recommendation ACG guidelines ESPGHAN and NASPGHAN guidelines
History and Symptoms
Physical Examination
Diagnostic tests Endoscopic tests Nonendoscopic tests
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Helicobacter pylori infection medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Helicobacter pylori infection medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Helicobacter pylori infection medical therapy
CDC on Helicobacter pylori infection medical therapy
Helicobacter pylori infection medical therapy in the news
Blogs on Helicobacter pylori infection medical therapy
Directions to Hospitals Treating Helicobacter pylori infection
Risk calculators and risk factors for Helicobacter pylori infection medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Primary Treatment for H.pylori Infection

Primary Therapy	Sequential Therapy
PPI+Clarithromycin+Amoxicillin or metronidazole (Clarithromycin-based triple therapy) 14 days or PPI or H2RA+ Bismuth+Metronidazole+Tetracycline (Bismuth quadruple therapy) 10-14days	PPI+ Amoxicillin 5 days Followed by PPI+Clarithromycin+Tinidazole Additional 5 days (Alternative to clarithromycin-based triple or bismuth quadruple therapy)
Recommended treatment in the United States	Requires validation in the United States before it can be recommended as a first line therapy